Navigation Links
St. Mary Announces Major Expansion in Cardiology Capabilities
Date:4/16/2008

With a $30 million investment, two new, state-of-the-art cardiac

catheterization labs open in 2008 to serve the community

LANGHORNE, Pa., April 16 /PRNewswire/ -- St. Mary Medical Center today announced that it will expand its cardiology services by adding two new, state-of-the-art procedure rooms to its cardiac catheterization labs (cath labs). Currently home to three procedure rooms, St. Mary will invest more than $30 million to make this upgrade to meet the growing healthcare needs of the community. To date, nearly 35,000 procedures (nearly 4,000 procedures annually) have been performed in the cath labs, making the St. Mary cardiology team one of the region's most experienced. Since the cath labs were last expanded in 1999, the service has experienced a greater than 88 percent increase in patient volume.

"The cardiac team at St. Mary has performed many catheterizations and those numbers are expected to increase," notes Director of Cardiac Catheterization Laboratories Dr. Ronald Fields. "With that being said, experience only goes so far. By adding these new procedure rooms St. Mary is equipping us with the tools we need to complement our collective experience."

Since the addition of a third procedure room in 1999, the St. Mary Medical Center cath labs have experienced more than an 88 percent increase in patient volume. In addition, 93 percent of adults living in Bucks County have at least one cardiac risk factor, suggesting that patient volume will continue to grow in the coming years. To keep pace with this increase in procedures, St. Mary is initiating a multiyear refurbishment of its cardiac catheterization capabilities. In addition to increasing the availability of time slots in the lab that leads to shorter wait times for procedures, the expansion efforts allow St. Mary to expand its technological offerings.

"We have a talented staff at St. Mary Medical Center, and the availability of state-of-the-art facilitie
'/>"/>

SOURCE St. Mary Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Internet Sleep Disorders information and Treatment site ... sleep problems with herbal or natural sleep aids ... ,insomnia remedies for a good cause. The submissions ... Natural Sleep Aids ,Encyclopedia, by YOU, to be ... The site will donate 100% of the proceeds ...
(Date:12/5/2009)... a phase 1/2 clinical trial that it is ... newly diagnosed with multiple myeloma, a cancer of white ... Cancer Institute. , Partial responses or better were seen ... drug combination in the multi-center study, with 74 percent ... phase 2 population, reports Paul G. Richardson, MD, of ...
(Date:12/5/2009)... CAPE TOWN, South Africa, December 5 The ... outskirts of Cape Town opened its doors,today (5 ... joined by,Western Cape Premier Helen Zille, 2010 FIFA ... Jordaan, South African Football Association,President Kirsten Nematandani and ...
(Date:12/5/2009)... Take steps to eliminate triggers, experts advise , , SATURDAY, ... people with allergies and asthma can have bad reactions ... steps to prevent sneezing and wheezing, according to the ... Those who are allergic to live evergreens may choose ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... Encision Inc. (OTC Bulletin Board: ECIA), a medical device ... a standard of care in minimally-invasive surgery, reported its ... ended March 31, 2009.Net sales for the fourth quarter ... $3.1 million, representing a 3% decrease over net sales ...
... Cardiva Medical, Inc. announced today that it has ... (FDA) for its latest technology, the Cardiva Catalyst III, ... device in the market. Built upon its predecessor, ... drug which neutralizes heparin in the tissue adjacent to ...
... Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer ... and nutraceutical products, today announced that its monthly investor ... 2009 at 4:30 PM Eastern Time. To participate ... (international). The call will also be webcast. ...
... time athlete,s foot sufferers and parents.KENILWORTH, N.J., May ... (NYSE: SGP ) today announced the ... the treatment of athlete,s foot. TINACTIN CHILL is ... powder spray.(Photo: http://www.newscom.com/cgi-bin/prnh/20090519/NY19030 )To view ...
... Strategies for Optimizing CHO Performance" inside the BIO Process Product Zone ... ... Fort Collins, CO (PRWEB) May 19, 2009 -- Amidst the sea ... will be InVitria, a cell culture media supplement company that provides ...
... Developed by a Crohn,s patient with help from GI ... Inc., allows patients with (IBD) Crohn,s and Ulcerative Colitis ... their doctors.UPPER SADDLE RIVER, N.J., May 19 WellApps, ... (IBD) Crohn,s and Ulcerative Colitis provide accurate symptom data ...
Other Medicine News:Health News:Encision Reports Fourth Quarter and Fiscal Year 2009 Results 2Health News:Encision Reports Fourth Quarter and Fiscal Year 2009 Results 3Health News:Encision Reports Fourth Quarter and Fiscal Year 2009 Results 4Health News:Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device 2Health News:Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device 3Health News:Nuvilex, Inc. Announces Monthly Investor Conference Call 2Health News:Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males 2Health News:InVitria to Present at BIO 2009 International Convention in Atlanta 2Health News:IBD Patient Launches iPhone Application to Help Doctors Treat Crohn's and Ulcerative Colitis 2
(Date:12/4/2009)... The U.S. Food and Drug Administration (FDA) today approved ... the treatment of schizophrenia and manic or mixed episodes ... years old. ,, The updated Zyprexa label states ... for weight gain and hyperlipidemia in adolescents compared to ...
(Date:12/4/2009)... Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, ... chapter of the American Red Cross are hard at ... that they endure that could potentially put Philadelphia,s blood ... on strike and set up a picket line yesterday ...
(Date:12/4/2009)... Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: ... enrolled in the company,s Phase II-b, dose escalation, clinical ... traumatic brain injury (TBI). Oxycyte is the Company,s perfluorocarbon ... invaluable importance in improving the outcome of patients with ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Constipation May Lead to Other Problems 50223 1Constipation May Lead to Other Problems 50223 2Constipation May Lead to Other Problems 50223 3Jackson International Launches New Website in Collaboration with Medicaview International 50220 1Jackson International Launches New Website in Collaboration with Medicaview International 50220 2Jackson International Launches New Website in Collaboration with Medicaview International 50220 3Jackson International Launches New Website in Collaboration with Medicaview International 50220 4The science of hammering 9025 1
Polyester ribbons (3) impregnated with different OD values of conjugated Protein A...
Polyester ribbon impregnated with conjugated Protein A - .25 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Sol, 40 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: